Skip to main content

Table 6 Comparison between group I (control group) and group II (case group) regarding levels of hemoglobin, AST, ALT, albumin, total bilirubin, INR, platelets, and creatinine 12 weeks after treatment

From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

  Group I Group II Test value p value
Hemoglobin Mean ± SD 12.36 ± 1.62 8.92 ± 1.63 10.021 0.001
Range 8.8–15.7 4.2–12.4
AST (U/L) Normal 50 (100%) 40 (95.2%) 2.434 0.119
High 0 (0%) 2 (4.8%)
ALT (U/L) Normal 50 (100%) 40 (95.2%) 2.434 0.119
High 0 (0%) 2 (4.8%)
Albumin (gm/dl) Mean ± SD 4.25 ± 0.35 3.89 ± 0.41 4.682 0.001
Range 3.5–5.1 2.9–4.8
Bilirubin (mg/dl) Mean ± SD 0.87 ± 0.43 0.70 ± 0.33 2.019 0.047
Range 0.3–2.6 0.1–1.9
INR Mean ± SD 1.09 ± 0.08 1.08 ± 0.11 0.592 0.555
Range 1–1.26 0.88–1.36
Platelets (103/mm3) Mean ± SD 242.57 ± 69.99 233.35 ± 91.59 0.538 0.592
Range 155–501 114–570
Creatinine (mg/dl) Median(IQR) 0.9 (0.8–1) 7 (5.87–8.9) − 8.051 0.001
Range 0.6–1.2 3.6–12.8